Delivery Order SPE2DB24D1021-SPE2DB25FFALY
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $22,724.80 from the Defense Logistics Agency's Medical Supply Chain on September 9, 2025. This firm fixed-price contract, with an ultimate completion date of September 10, 2025, represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $134,839.30 on September 10, 2025, by the Defense Logistics Agency's Medical Supply Chain. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of September 11, 2025, and represents a child contract under the company's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,060.31 from the Defense Logistics Agency's Medical Supply Chain on August 25, 2025. This firm fixed price delivery order, which is expected to be completed by August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $61,743.15 from the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $169,917.60 from the Defense Logistics Agency's Medical Supply Chain on September 3, 2025. This firm fixed-price delivery order, which is a non-set-aside award, is set for completion by September 4, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $38,784.40 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which has an ultimate completion date of August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,441.12 on August 11, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company serves as...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,336.48 on July 31, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 1, 2025. The contract serves as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $139,449.98 from the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and was competitively awarded without set-aside designation. This delivery order represents a child contract action under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,514.52 on August 28, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, with an ultimate completion date of August 29, 2025, represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFALYDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,348.76 from the Defense Logistics Agency (DLA) on September 9, 2025, with an ultimate completion date of September 10, 2025. The award is for 16,000 unit capsules of Pertzye DR 100s, a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency. This delivery order was competitively awarded with no set-aside designation and carries firm fixed pricing terms. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This delivery order supports the DLA's Medical Supply Chain mission to provide pharmaceutical products and medical supplies to military healthcare systems and other federal medical procurement needs. AmerisourceBergen's comprehensive IDC vehicle enables the company to supply a diverse range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs globally. The company's selection as a prime vendor reflects its demonstrated capability to meet federal procurement requirements through open competition and deliver critical medical commodities to authorized customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/9/25 |